MALAT1 and epilepsy: In a more recent study based on HCN candidate-gene screening of a small cohort of patients (n = 113), our group characterized for the first time a loss-of-function HCN2 mutation that could be shown from functional studies to be directly involved in human epilepsy (Figure 1).